LifeVantage Corporation announced its financial results for the first quarter of fiscal 2027. Revenue during the period was $37.1 million, a 22% year-over-year decrease. Revenue in the Americas fell 22.2% to $29 million while revenue in the Asia/Pacific & Europe region fell 21.2% to $8.2 million. The company attributed this decline primarily to lower active accounts, reflecting impacts from the broader macro environment and lower sales of the MindBody GLP-1 System. These declines were partially offset, however, by sales of the LoveBiome product line, which LifeVantage acquired in October of 2025.

LifeVantage Corporation celebrated a successful Global Kickoff event that encouraged consultants worldwide to unlock new levels of leadership, impact and business growth. Themed “Breakthrough,” the virtual event was designed to set the tone for 2026, casting vision for a year of growth, innovation and momentum.

LifeVantage Corporation welcomed thousands of consultants from across the US to its Momentum Academy 2025 in Dallas, Texas. This was the first significant in-person event to integrate representatives from LoveBiome into the LifeVantage community and was an opportunity to boost engagement and alignment across the two brands’ markets, products, culture and leadership. It also marked […]

LifeVantage Corporation announced the strategic acquisition of LoveBiome, a direct sales company focused on microbiome care and wellness solutions. The definitive agreement will allow LifeVantage to incorporate LoveBiome’s leadership in the emerging microbiome health sector into its current wellness mission to activate optimal health processes at the cellular level.